The benefits of using a nimble platform from phase to phase
By streamlining data entry and reducing complex paperwork, digital platforms can reduce costs and timelines for clinical trials. While SaaS …
Post
-
-
Avistone Met inhibitor Phase I trial cleared for sites in Canada
Beijing Avistone Biotechnology’s Phase I trial evaluating its candidate for mesenchymal epithelial transition (MET) alteration solid tumour treatment has been …
-
FDA lifts clinical hold on Avidity’s lead antibody conjugate therapy trial
The US Food and Drug Administration (FDA) has lifted the partial clinical hold on Avidity Biosciences’ investigational drug, delpacibart etedesiran …
-
MILOS study: The real-world use of bempedoic acid
Daiichi Sankyo has announced the final two-year follow-up data from the German cohort of the MILOS study. The MILOS study …
-
Island Pharmaceuticals trials prevention and therapy benefit of dengue drug
Island Pharmaceuticals has dosed all participants in the first stage of a Phase II trial investigating its dengue fever candidate …
-
Leading Cybersecurity Companies in Clinical Trials
Clinical trial software is vulnerable to breaches and ransomware attacks, as clinical trials become more decentralised and incorporate the use …
-
Clinical Pharmacology Services & Companies in Clinical Research
Clinical pharmacology services help in the rational introduction of new medicines into healthcare. It is critical for new target molecules …
-
Clinical Trial Monitoring Services & Companies in Clinical Research
Clinical trial monitoring service companies help oversee the progress of clinical trials and ensure they are conducted, recorded, and reported …
-
NHS launches study of newborn blood test to detect 200 rare conditions
England’s National Health Service (NHS) has kick started a study which will screen up to 100,000 newborn babies for over …
-
Immutep concludes participant enrolment in Phase II breast cancer trial
Immutep has announced the conclusion of subject enrolment in the Phase II segment of the AIPAC-003 clinical trial of eftilagimod …
-
Palvella secures FDA grant for Phase III microcystic LMs treatment trial
Palvella Therapeutics has received a grant of up to $2.6m from the US Food and Drug Administration (FDA) Office of …
-
Abivax enrols first participant in Phase IIb Crohn’s disease drug trial
Abivax has enrolled the first subject in the Phase IIb ENHANCE-CD clinical trial of its lead investigational drug candidate obefazimod …
-
Summit completes subject enrolment in Phase III NSCLC treatment trial
Summit Therapeutics has concluded subject enrolment in the Phase III HARMONi clinical trial of ivonescimab, along with platinum-doublet chemotherapy for …
-
Cloud-Based Clinical Trials Solutions & Companies
Cloud-based clinical trials can reduce the huge expense and long lead times of traditional clinical trials. Clinical data sharing improves …
-
Women are dying unnecessarily due to the underdiagnosis of heart disease
In the UK, heart disease is the leading cause of death in women. As heart disease is historically more prevalent …
